Search by Drug Name or NDC

    NDC 70710-1726-08 Nelarabine 5 mg/mL Details

    Nelarabine 5 mg/mL

    Nelarabine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is NELARABINE.

    Product Information

    NDC 70710-1726
    Product ID 70710-1726_aec0ec2a-d34b-480e-9d6e-d2fb681d9af8
    Associated GPIs 21300052002020
    GCN Sequence Number 059981
    GCN Sequence Number Description nelarabine VIAL 250MG/50ML INTRAVEN
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 25932
    HICL Sequence Number 033304
    HICL Sequence Number Description NELARABINE
    Brand/Generic Generic
    Proprietary Name Nelarabine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Nelarabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name NELARABINE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215037
    Listing Certified Through 2024-12-31

    Package

    NDC 70710-1726-08 (70710172608)

    NDC Package Code 70710-1726-8
    Billing NDC 70710172608
    Package 6 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-8) / 50 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2021-11-17
    NDC Exclude Flag N
    Pricing Information N/A